The content on this site is intended for healthcare professionals only
Dr Alberto Zamo speaks with ecancertv at BSH 2016 about current affairs in haematopathology.
Currently, few laboratories have access to next generation sequencing technology, influencing regional abilities to reach accurate diagnoses.
Dr Zamo describes the promising potential for affordable access to genomic techniques and improved patient risk stratification in the near future.
ecancer's filming at ICMM 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.
Transforming cancer care in India: The Access Cancer Care Initiative
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Synthetic biology and precision medicine in blood and gynaecological cancers
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for September 15-21, 2023
OncoAlert Round Up for August 25th - 31st, 2023
The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer
Lung cancer screening and treatment in the Philippines
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
